1. Genome-scale genetic screening identifies PRMT1 as a critical vulnerability in castration-resistant prostate cancer. (October 2020) Authors: Tang, S.; Metaferia, N.; Nogueira, M.; Gelbard, M.; Alaiwi, S. Abou; Seo, J.H.; Hwang, J.; Strathdee, C.; Baca, S.; Li, J.; Abuhammad, S.; Zhang, X.; Doench, J.; Hahn, W.; Takeda, D.; Freedman, M.; Choi, P.; Viswanathan, S. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗